For this, we have employed the VHH B9 targeting CAIX, which localizes to peri-necrotic regions of tumours [11], and the VHH 11A4 targeting HER2, which is known to have a more homogenous distribution throughout the tumour tissue [7]. This evidence concerns the gene CA9 and neoplasm.